Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma.

Authors
Bernstein-DI; Cartier-A; Cote-J; Malo-JL; Boulet-LP; Wanner-M; Milot-J; L'Archeveque-J; Trudeau-C; Lummus-Z
Source
Am J Respir Crit Care Med 2002 Aug; 166(4):445-450
NIOSHTIC No.
20029474
Abstract
We previously reported that diisocyanate-human serum albumin (DIISO-HSA) stimulated production of monocyte chemoattractant protein-1 (MCP-1) by peripheral blood mononuclear cells is significantly associated with a clinical diagnosis of diisocyanate asthma (DA). Others have reported that antibodies for DIISO-HSA are specific but insensitive markers of DA. This study was performed to evaluate test characteristics of the in vitro MCP-1 assay compared with DIISO-HSA-specific immunoglobulin (Ig) G and IgE in identifying workers with DA. MCP-1 was quantitated in peripheral blood mononuclear cell supernatants 48 hours after incubation with DIISO-HSA antigens. Assay results were compared with outcomes of specific inhalation challenge (SIC) testing. Nineteen of 54 (35%) workers assayed for antibodies and MCP-1 stimulation had SIC-confirmed DA. Mean MCP-1 produced by SIC-positive workers was greater than SIC-negative workers (p < or = 0.001). Diagnostic sensitivity, specificity, and test efficiency for specific IgG were 47%, 74%, and 65%, respectively, and for specific IgE were 21%, 89%, and 65%, respectively. Sensitivity, specificity, and test efficiency of the MCP-1 test were 79%, 91%, and 87%, respectively. This study indicates that the MCP-1 stimulation assay has greater sensitivity and specificity than the specific antibody assays in correctly identifying DA.
Keywords
Pulmonary-system-disorders; Bronchial-asthma; Respiratory-system-disorders; Humans; Genotoxic-effects; Biological-factors; Biomarkers; Worker-health; Workers; Author Keywords: occupational asthma; diisocyanate; MCP-1; antibody
Contact
Department of Internal Medicine, Division of Immunology, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267-0563
CODEN
AJCMED
Publication Date
20020815
Document Type
Journal Article
Email Address
bernstdd@email.uc.edu
Funding Amount
1343329
Funding Type
Grant
Fiscal Year
2002
NTIS Accession No.
NTIS Price
Identifying No.
Grant-Number-R01-OH-003519
Issue of Publication
4
ISSN
1073-449X
Source Name
American Journal of Respiratory and Critical Care Medicine
State
OH
Performing Organization
University of Cincinnati, Cincinnati, OH
TOP